Tioga Cardiovascular Launches Innovative Luna™ TMVR System
Tioga Cardiovascular, Inc., a leader in medical innovations, has made a significant advancement with the introduction of its Luna™ transcatheter mitral valve replacement (TMVR) system. This new device was successfully employed in the first-in-human trans-septal implantations, demonstrating remarkable outcomes.
The Groundbreaking Cases
Physicians achieved excellent hemodynamic results in the initial patients following the procedure. The remarkable success of these cases was spearheaded by experienced medical professionals who collaborated closely with the Tioga team. Notably, Dr. Adrian Ebner and Dr. Irakli Gogorishvili were instrumental in performing these pioneering procedures. Their collaboration with leading U.S. physicians, including Dr. Azeem Latib, Dr. Susheel Kodali, Dr. Edwin C.W. Ho, Dr. Gagan Singh, and Dr. Vinnie Bapat, underscores the commitment to excellence in cardiovascular care.
Challenges of Mitral Valve Interventions
Dr. Latib from Montefiore Medical Center pointed out that mitral valve interventions present unique challenges due to their complex anatomy. The proximity of the left ventricular outflow tract (LVOT) and the variety of annular sizes significantly complicate the procedure. The Luna TMVR system is thoughtfully designed to navigate these issues, offering a promising solution for patients requiring mitral valve replacements.
Moving Forward with the Luna System
Mike Dineen, the President and CEO of Tioga Cardiovascular, expressed his enthusiasm for this pivotal moment in the company's journey. He emphasized the team's dedication to clinical excellence, stating, "This is an exciting milestone for Tioga. We are eager to conduct more clinical cases using our Luna TMVR system." A special mention was made of the appreciation for the clinical investigators, highlighting their essential role in these initial cases.
Upcoming Presentation at the TCT Conference
The Luna TMVR system will be showcased at the upcoming session entitled "Innovations in Transcatheter Mitral Valve Replacement Technologies" within the Transcatheter Cardiovascular Therapeutics (TCT) conference. This presentation is anticipated to draw significant attention from cardiovascular professionals eager to learn about the latest advancements in the field and will take place shortly.
About Tioga Cardiovascular
Tioga Cardiovascular is a privately held company under the Shifamed LLC portfolio, focusing on creating advanced solutions for mitral valve replacement. Their goal is to simplify procedures while employing less invasive techniques through transcatheter approaches. By prioritizing patient outcomes and streamlined processes, Tioga is setting new standards in cardiac care.
About Shifamed, LLC
Shifamed, LLC was founded by entrepreneur Amr Salahieh and serves as a specialized hub for medical innovation. The organization is dedicated to developing solutions that expedite market readiness while reducing risks and enhancing the impact of medical technologies. This mission is geared towards improving the quality of life for patients around the world.
Frequently Asked Questions
What is the Luna TMVR system?
The Luna TMVR system is a transcatheter mitral valve replacement technology designed to improve the safety and efficacy of mitral valve procedures.
Who performed the first-in-human procedures for the Luna TMVR?
The initial procedures were conducted by Dr. Adrian Ebner and Dr. Irakli Gogorishvili, supported by a team of leading U.S. cardiovascular experts.
What are the expected benefits of the Luna TMVR system?
The Luna TMVR system aims to offer easier and less invasive solutions for mitral valve replacements, potentially improving patient recovery times and outcomes.
When will more information about the Luna system be shared?
Additional details about the Luna TMVR system will be presented during the TCT conference.
How does Tioga Cardiovascular plan to further develop this technology?
Tioga Cardiovascular intends to conduct further clinical cases and gather data to enhance the development and adoption of the Luna TMVR system.
